Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-28 9:47 pm Purchase |
2025-03-25 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 1,028,086 27.900% |
187,187 (+22.26%) |
Filing History |
| 2023-12-05 4:00 pm Purchase |
2023-11-30 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 840,899 26.900% |
322,435 (+62.19%) |
Filing History |
| 2023-05-23 4:00 pm Purchase |
2023-05-19 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 518,464 19.990% |
518,464 (New Position) |
Filing History |
| 2023-05-12 08:39 am Purchase |
2023-05-11 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 518,465 19.990% |
307,482 (+145.74%) |
Filing History |
| 2023-04-03 07:30 am Purchase |
2023-03-31 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 210,983 9.200% |
980 (+0.47%) |
Filing History |
| 2022-11-21 5:00 pm Purchase |
2022-11-20 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 210,003 9.200% |
30,169 (+16.78%) |
Filing History |
| 2021-06-07 5:21 pm Purchase |
2021-06-03 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 179,833 8.600% |
41,159 (+29.68%) |
Filing History |
| 2021-05-14 4:56 pm Purchase |
2021-05-04 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 138,675 7.800% |
138,675 (New Position) |
Filing History |